Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells

Faith B. Davis, Heng Yuan Tang, Ai Shih, Travis Keating, Lawrence Lansing, Aleck Hercbergs, Robert A. Fenstermaker, Ahmed Mousa, Shaker A. Mousa, Paul J. Davis, Hung Y. Lin

研究成果: 雜誌貢獻文章同行評審

153 引文 斯高帕斯(Scopus)

摘要

Recent evidence suggests that the thyroid hormone L-thyroxine (T 4) stimulates growth of cancer cells via a plasma membrane receptor on integrin αVβ3. The contribution of this recently described receptor for thyroid hormone and receptor-based stimulation of cellular mitogen-activated protein kinase [MAPK; extracellular signal-regulated kinase 1/2 (ERK1/2)] activity, to enhancement of cell proliferation by thyroid hormone was quantitated functionally and by immunologic means in three glioma cell lines exposed to T4. At concentrations of 1 to 100 nmol/L, T4 caused proliferation of C6, F98, and GL261 cells, measured by accumulation of proliferating cell nuclear antigen (PCNA) and radiolabeled thymidine incorporation. This effect was inhibited by the T 4 analogue, tetraiodothyroacetic acid, and by an α Vβ3 RGD recognition site peptide, both of which block T4 binding to integrin αVβ3 but are not agonists. Activation of MAPK by T4 was similarly inhibited by tetraiodothyroacetic acid and the RGD peptide. The thyroid hormone 3,5,3′-triiodo-L-thyronine (T3) and T4 were equipotent stimulators of PCNA accumulation in C6, F98, and GL261 cells, but physiologic concentrations of T3 are 50-fold lower than those of T4. In conclusion, our studies suggest that glioblastoma cells are thyroid hormone dependent and provide a molecular basis for recent clinical observations that induction of mild hypothyroidism may improve duration of survival in glioblastoma patients. The present experiments infer a novel cell membrane receptor-mediated basis for the growth-promoting activity of thyroid hormone in such tumors and suggest new therapeutic approaches to the treatment of patients with glioblastoma.
原文英語
頁(從 - 到)7270-7275
頁數6
期刊Cancer Research
66
發行號14
DOIs
出版狀態已發佈 - 七月 15 2006
對外發佈

ASJC Scopus subject areas

  • 癌症研究
  • 腫瘤科

指紋

深入研究「Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells」主題。共同形成了獨特的指紋。

引用此